Rome, the Child Jesus identifies 16 new rare diseases, they have not yet diagnosed

inscribed by the Infant Jesus in the Regional Network of Rare Diseases, the case considered the most important at the national level, and not only in the pediatric field. More than 700 Bambino Gesù people involved in research, including about 400 researchers and 300 doctors, biologists and pharmacists involved in both clinical activity and scientific research.

The hospital – explained in a note – is placed at the heads of the Network of Scientific Institutes of Hospitalization and Treatment (IRCCS) and first among Italian pediatric hospitals by factor level. impact (FI), the value that measures the weight of scientific publications. Child Jesus IF has increased by 50% in the last 5 years, reaching a level of 2,703 in 2017, for a total of 663 scientific publications. 438 active research projects last year, 36% of which involved rare diseases and cancers. 293 formalized scientific collaborations with national and especially international partners (77%), notably Germany, the United Kingdom, the Netherlands, France and the United States. 431 clinical trials involving 6,120 patients. The value of the entire biomedical technology park of the hospital is 73 million euros, for a total of 11,400 devices and components.